Bohlin Garen G
- SEC CIK
- 0001254705
In the past year, 1 open-market sale filing worth $323.5K and no purchases.
Current role at each company
- KPTI Karyopharm Therapeutics Inc.Directoras of May 26, 2026
- COLL Collegium Pharmaceutical, IncDirectoras of May 18, 2026
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- $323.5K
- 1 filing
- Net
- −$323.5K
- Bought minus sold
- Companies
- 1
- With open-market trades
Trades
Every Form 4 that lists Bohlin Garen G as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
COLL Collegium Pharmaceutical, Inc
Director2 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| May 13, 2026 (view filing) | May 11 | 2 days | Bohlin Garen GDirector | SSale | −8.70K | $37.18 | −$323.5K | −12.3%62.3K after | |
| May 16, 2024 (view filing) | May 14 | 2 days | Bohlin Garen GDirector | SSale | −29.0K | $32.30 | −$936.2K | −39.3%44.8K after |
KPTI Karyopharm Therapeutics Inc.
Director1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Sep 12, 2023 (view filing) | Sep 12 | Same day | Bohlin Garen GDirector | PPurchase | +41.1K | $1.22 | +$50.2K | +1,028.5%45.1K after |